2020 International Society of Hypertension global hypertension practice guidelines

Thomas Unger¹, Claudio Borghi², Fadi Charchar^{3

4

5}, Nadia A Khan^{6

7}, Neil R Poulter⁸, Dorairaj Prabhakaran^{9

10

11}, Agustin Ramirez¹², Markus Schlaich^{13

14}, George S Stergiou¹⁵, Maciej Tomaszewski^{16

17}, Richard D Wainford^{18

19

20}, Bryan Williams²¹, Aletta E Schutte^{22

23}

Affiliations

¹ CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Federation University Australia, School of Health and Life Sciences, Ballarat.
⁴ Department of Physiology, University of Melbourne, Melbourne, Australia.
⁵ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
⁶ University of British Columbia.
⁷ Center for Health Evaluation and Outcomes Sciences, Vancouver, Canada.
⁸ Imperial Clinical Trials Unit, Imperial College London, UK.
⁹ Public Health Foundation of India.
¹⁰ Centre for Chronic Disease Control, New Delhi, India.
¹¹ London School of Hygiene and Tropical Medicine, UK.
¹² Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina.
¹³ Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth.
¹⁴ Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
¹⁵ Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.
¹⁶ Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester.
¹⁷ Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester, Manchester, UK.
¹⁸ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston.
¹⁹ The Whitaker Cardiovascular Institute, Boston University.
²⁰ Department of Health Sciences, Boston University Sargent College, Boston, Massachusetts, USA.
²¹ University College London, NHR University College London, Hospitals Biomedical Research Centre, London, UK.
²² Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, Australia.
²³ Hypertension in Africa Research Team, South African MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.

PMID: 32371787
DOI: 10.1097/HJH.0000000000002453

2020 International Society of Hypertension global hypertension practice guidelines

Thomas Unger et al. J Hypertens. 2020 Jun.

. 2020 Jun;38(6):982-1004.

doi: 10.1097/HJH.0000000000002453.

Authors

Affiliations

¹ CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Federation University Australia, School of Health and Life Sciences, Ballarat.
⁴ Department of Physiology, University of Melbourne, Melbourne, Australia.
⁵ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
⁶ University of British Columbia.
⁷ Center for Health Evaluation and Outcomes Sciences, Vancouver, Canada.
⁸ Imperial Clinical Trials Unit, Imperial College London, UK.
⁹ Public Health Foundation of India.
¹⁰ Centre for Chronic Disease Control, New Delhi, India.
¹¹ London School of Hygiene and Tropical Medicine, UK.
¹² Hypertension and Metabolic Unit, University Hospital, Favaloro Foundation, Buenos Aires, Argentina.
¹³ Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit, University of Western Australia, Perth.
¹⁴ Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
¹⁵ Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.
¹⁶ Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester.
¹⁷ Division of Medicine and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust Manchester, Manchester, UK.
¹⁸ Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston.
¹⁹ The Whitaker Cardiovascular Institute, Boston University.
²⁰ Department of Health Sciences, Boston University Sargent College, Boston, Massachusetts, USA.
²¹ University College London, NHR University College London, Hospitals Biomedical Research Centre, London, UK.
²² Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, Australia.
²³ Hypertension in Africa Research Team, South African MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.

PMID: 32371787
DOI: 10.1097/HJH.0000000000002453

No abstract available

PubMed Disclaimer

Comment in

2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence.
Pareek A, Ram CVS, Joshi S, Mehta RT. Pareek A, et al. J Hypertens. 2020 Nov;38(11):2335-2336. doi: 10.1097/HJH.0000000000002601. J Hypertens. 2020. PMID: 33027113 No abstract available.
Reply.
Poulter N, Williams B, Unger T; 2020 ISH Global Hypertension Practice Guidelines Committee. Poulter N, et al. J Hypertens. 2020 Nov;38(11):2336-2337. doi: 10.1097/HJH.0000000000002602. J Hypertens. 2020. PMID: 33027114 No abstract available.
Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype.
Spence JD. Spence JD. J Hypertens. 2020 Nov;38(11):2338. doi: 10.1097/HJH.0000000000002611. J Hypertens. 2020. PMID: 33027115 No abstract available.
Reply.
Schlaich MP, Borghi C, Tomaszewski M, Stergiou GS, Schutte AE, Unger T; 2020 ISH Global Hypertension Practice Guidelines Committee. Schlaich MP, et al. J Hypertens. 2020 Nov;38(11):2339-2340. doi: 10.1097/HJH.0000000000002612. J Hypertens. 2020. PMID: 33027116 No abstract available.
2020 International Society of Hypertension global hypertension practice guidelines - lifestyle modification.
Schneider RH, Salerno J, Brook RD. Schneider RH, et al. J Hypertens. 2020 Nov;38(11):2340-2341. doi: 10.1097/HJH.0000000000002625. J Hypertens. 2020. PMID: 33027117 No abstract available.
Reply.
Schutte AE, Charchar F, Prabhakaran D; 2020 ISH Global Hypertension Practice Guidelines Committee. Schutte AE, et al. J Hypertens. 2020 Nov;38(11):2341. doi: 10.1097/HJH.0000000000002626. J Hypertens. 2020. PMID: 33027118 No abstract available.
Intensive blood pressure-lowering strategy should also be offered to older patients.
Kow CS, Hasan SS. Kow CS, et al. J Hypertens. 2021 Apr 1;39(4):812-813. doi: 10.1097/HJH.0000000000002778. J Hypertens. 2021. PMID: 33649284 No abstract available.
Reply.
Williams B, Unger T, Schutte AE, Tomaszewski M, Poulter NR; 2020 ISH Global Hypertension Practice Guidelines Committee. Williams B, et al. J Hypertens. 2021 Apr 1;39(4):813-814. doi: 10.1097/HJH.0000000000002779. J Hypertens. 2021. PMID: 33649285 No abstract available.

References

1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36:1953–2041.
1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:1269–1324.
1. Global Burden of Disease Risk Factor CollaboratorsGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1923–1994.
1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016; 134:441–450.
1. Non-communicable Disease Risk Factor CollaborationWorldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389:37–55.

Grants and funding

MC_PC_13090/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

2020 International Society of Hypertension global hypertension practice guidelines

Affiliations

2020 International Society of Hypertension global hypertension practice guidelines

Authors

Affiliations

Comment in

References

Grants and funding

LinkOut - more resources

Full Text Sources

Medical